Clinical trial
Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions…
NCT00001365 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00001365 |
|---|---|
| Title | Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System |
| Official title | NMDA Receptor Antagonist Treatment of Neurodegenerative Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neurodegenerative Disease, Parkinson's Disease |
| Intervention type | Drug |
| Interventions | dextromethorphan |
| Enrollment | 42 |
| Start date | Jul 1, 1993 |
| Completion | Jun 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Jul 13, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: